100% Same
Salt CompositionEffectivenessStrength
Top Branded
Substitute
You Searched


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
Xilingio 10 5mg Tablet 10s is a fixed-dose combination medicine specifically designed to improve blood sugar control in adults with Type 2 Diabetes Mellitus. It contains Empagliflozin (an SGLT2 inhibitor) and Linagliptin (a DPP-4 inhibitor), which work together to reduce high blood sugar levels. This dual-action treatment not only helps manage diabetes effectively but also offers significant benefits for cardiovascular health and kidney protection. Healthcare professionals often recommend this combination to enhance glycaemic control when monotherapy is insufficient.
Xilingio 10 5mg Tablet 10s is an advanced, dual-therapy prescription for the long-term management of Type 2 Diabetes Mellitus. This medication combines two distinct mechanisms of action for superior glycaemic control. The first component, Empagliflozin, belongs to the Sodium-Glucose Co-transporter 2 (SGLT2) inhibitor class. It works by blocking SGLT2 in the kidneys, preventing glucose from being reabsorbed back into the bloodstream and increasing glucose excretion via the urine. This leads to a reduction in blood sugar levels and, importantly, has been shown to reduce the risk of cardiovascular events and slow the progression of chronic kidney disease in diabetic patients.
The second component, Linagliptin, is a Dipeptidyl Peptidase-4 (DPP-4) inhibitor. It enhances the body's natural ability to lower blood sugar by increasing the levels of active incretin hormones. These hormones stimulate the pancreas to produce more insulin when blood sugar levels are high and decrease the amount of glucose produced by the liver. The synergistic effect of Empagliflozin and Linagliptin in Xilingio 10 5mg Tablet 10s results in a more comprehensive and sustained reduction in HbA1c levels than either drug alone. Consistent, once-daily use, combined with diet and exercise, is crucial for protecting the heart and kidneys and dramatically lowering the long-term complications of uncontrolled diabetes.
The primary uses of Xilingio 10 5mg Tablet 10s (Empagliflozin 25mg + Linagliptin 5mg) are centred on the treatment and proactive management of Type 2 Diabetes Mellitus:
While Xilingio 10 5mg Tablet 10s is generally well-tolerated, some side effects may occur. Most are mild and often lessen as the body adjusts:
Disclaimer: Consult your doctor if any side effects persist or worsen, or if you experience any signs of a severe reaction or infection.
Xilingio 10 5mg Tablet 10s is generally safe to take with most foods and can be taken with or without a meal. However, patients with Type 2 Diabetes should be mindful of their overall diet, as confident choices can impact the medicine's effectiveness:
Xilingio 10 5mg Tablet 10s can interact with other medications. Always inform your doctor about all current prescriptions and supplements.
Patients with certain pre-existing conditions must use Xilingio 10 5mg Tablet 10s with caution and under close medical supervision:
The standard recommended dosage of Xilingio 10 5mg Tablet 10s (Empagliflozin + Linagliptin) is one tablet once daily. It should be taken at the same time each day, with or without food, as part of your overall diabetes management plan. Your doctor will determine the exact dose based on your individual blood sugar control, existing medical conditions, and response to treatment. Never change your dose or stop the medication without consulting your healthcare provider.
If you miss a dose of Xilingio 10 5mg Tablet 10s, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to make up for a missed dose, as this increases the risk of side effects such as low blood sugar. Consistent daily intake is vital for maintaining optimal blood sugar control.
https://www.mayoclinic.org/drugs-supplements/empagliflozin-and-linagliptin-oral-route/description/drg-20137736
https://www.drugs.com/search.php?searchterm=Empagliflozin+and+linagliptin
https://www.webmd.com/drugs/2/drug-167715/glyxambi-oral/details
Therapeutic Class
Endocrinology/Diabetes Management
Action Class
Anti-diabetic/Hypoglycaemic Agent
Chemical Class
SGLT2 Inhibitor & DPP-4 Inhibitor
Habit Forming
No
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100

Download Now